References
- Slotman BJ and Rao BR (1988) Ovarian cancer (review). Etiology, diagnosis, prognosis, surgery, radiotherapy, chemotherapy and endocrine therapy. Anticancer Res 8, 417-434
- Aunoble B, Sanches R, Didier E and Bignon YJ (2000) Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review). Int J Oncol 16, 567-576
- Cannistra SA (2004) Cancer of the ovary. N Engl J Med 351, 2519-2529 https://doi.org/10.1056/NEJMra041842
- Martin LP and Schilder RJ (2009) Management of recurrent ovarian carcinoma: current status and future directions. Semin Oncol 36, 112-125 https://doi.org/10.1053/j.seminoncol.2008.12.003
- Kreso A and Dick JE (2014) Evolution of the cancer stem cell model. Cell Stem Cell 14, 275-291 https://doi.org/10.1016/j.stem.2014.02.006
- Zhan Q, Wang C and Ngai S (2013) Ovarian cancer stem cells: a new target for cancer therapy. Biomed Res Int 2013, 916819
- Burgos-Ojeda D, Rueda BR and Buckanovich RJ (2012) Ovarian cancer stem cell markers: prognostic and therapeutic implications. Cancer Lett 322, 1-7 https://doi.org/10.1016/j.canlet.2012.02.002
- Mosca E, Cocola C, Sabour D et al (2010) Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells. In Silico Biol 10, 207-221
- Ben-Porath I, Thomson MW, Carey VJ et al (2008) An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40, 499-507 https://doi.org/10.1038/ng.127
- Lee M, Nam EJ, Kim SW, Kim S, Kim JH and Kim YT (2012) Prognostic impact of the cancer stem cell-related marker NANOG in ovarian serous carcinoma. Int J Gynecol Cancer 22, 1489-1496 https://doi.org/10.1097/IGJ.0b013e3182738307
- Murr R, Vaissiere T, Sawan C, Shukla V and Herceg Z (2007) Orchestration of chromatin-based processes: mind the TRRAP. Oncogene 26, 5358-5372 https://doi.org/10.1038/sj.onc.1210605
- Murr R, Loizou JI, Yang YG et al (2006) Histone acetylation by Trrap-Tip60 modulates loading of repair proteins and repair of DNA double-strand breaks. Nat Cell Biol 8, 91-99 https://doi.org/10.1038/ncb1343
- Wurdak H, Zhu S, Romero A et al (2010) An RNAi screen identifies TRRAP as a regulator of brain tumor-initiating cell differentiation. Cell Stem Cell 6, 37-47 https://doi.org/10.1016/j.stem.2009.11.002
- Charles NA and Holland EC (2010) TRRAP and the maintenance of stemness in gliomas. Cell Stem Cell 6, 6-7 https://doi.org/10.1016/j.stem.2009.12.005
- Wang J, Shan M, Liu T et al (2016) Analysis of TRRAP as a Potential Molecular Marker and Therapeutic Target for Breast Cancer. J Breast Cancer 19, 61-67 https://doi.org/10.4048/jbc.2016.19.1.61
- McMahon SB, Wood MA and Cole MD (2000) The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc. Mol Cell Biol 20, 556-562 https://doi.org/10.1128/MCB.20.2.556-562.2000
- Nikiforov MA, Chandriani S, Park J et al (2002) TRRAP-dependent and TRRAP-independent transcriptional activation by Myc family oncoproteins. Mol Cell Biol 22, 5054-5063 https://doi.org/10.1128/MCB.22.14.5054-5063.2002
- Ichim G, Mola M, Finkbeiner MG, Cros MP, Herceg Z and Hernandez-Vargas H (2014) The histone acetyltransferase component TRRAP is targeted for destruction during the cell cycle. Oncogene 33, 181-192 https://doi.org/10.1038/onc.2012.570
- Herceg Z, Hulla W, Gell D et al (2001) Disruption of Trrap causes early embryonic lethality and defects in cell cycle progression. Nat Genet 29, 206-211 https://doi.org/10.1038/ng725
- Seo EJ, Kwon YW, Jang IH et al (2016) Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism. Stem Cells 34, 551-564 https://doi.org/10.1002/stem.2279
- Kim DK, Seo EJ, Choi EJ et al (2016) Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells. Exp Mol Med 48, e255 https://doi.org/10.1038/emm.2016.73
- Choi EJ, Seo EJ, Kim DK et al (2016) FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells. Oncotarget 7, 3506-3519
- Tapias A, Zhou ZW, Shi Y et al (2014) Trrap-dependent histone acetylation specifically regulates cell-cycle gene transcription to control neural progenitor fate decisions. Cell Stem Cell 14, 632-643 https://doi.org/10.1016/j.stem.2014.04.001
- Sawan C, Hernandez-Vargas H, Murr R et al (2013) Histone acetyltransferase cofactor Trrap maintains selfrenewal and restricts differentiation of embryonic stem cells. Stem Cells 31, 979-991 https://doi.org/10.1002/stem.1341
- Chen PB, Hung JH, Hickman TL et al (2013) Hdac6 regulates Tip60-p400 function in stem cells. Elife 2, e01557 https://doi.org/10.7554/eLife.01557
- Fazzio TG, Huff JT and Panning B (2008) An RNAi screen of chromatin proteins identifies Tip60-p400 as a regulator of embryonic stem cell identity. Cell 134, 162-174 https://doi.org/10.1016/j.cell.2008.05.031
- Jeter CR, Liu B, Liu X et al (2011) NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene 30, 3833-3845 https://doi.org/10.1038/onc.2011.114
- Wang ML, Chiou SH and Wu CW (2013) Targeting cancer stem cells: emerging role of Nanog transcription factor. Onco Targets Ther 6, 1207-1220
- Jeter CR, Yang T, Wang J, Chao HP and Tang DG (2015) Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions. Stem Cells 33, 2381-2390 https://doi.org/10.1002/stem.2007
- Seo EJ, Kim DK, Jang IH et al (2016) Hypoxia-Notch1-Sox2 signaling is important for maintaining cancer stem cells in ovarian cancer. Oncotarget 7, 55624-55638